• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

武汉 COVID-19 严重程度相关的风险因素。

Risk factors related to the severity of COVID-19 in Wuhan.

机构信息

Department of Pediatric, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, 430022, P.R. China.

Huazhong University of Science and Technology Hostipal. Luoyu Road 1037, Wuhan, 430074, P.R China.

出版信息

Int J Med Sci. 2021 Jan 1;18(1):120-127. doi: 10.7150/ijms.47193. eCollection 2021.

DOI:10.7150/ijms.47193
PMID:33390780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738952/
Abstract

To evaluate the characteristics at admission of patients with moderate COVID-19 in Wuhan and to explore risk factors associated with the severe prognosis of the disease for prognostic prediction. In this retrospective study, moderate and severe disease was defined according to the report of the WHO-China Joint Mission on COVID-19. Clinical characteristics and laboratory findings of 172 patients with laboratory-confirmed moderate COVID-19 were collected when they were admitted to the Cancer Center of Wuhan Union Hospital between February 13, 2020 and February 25, 2020. This cohort was followed to March 14, 2020. The outcomes, being discharged as mild cases or developing into severe cases, were categorized into two groups. The data were compared and analyzed with univariate logistic regression to identify the features that differed significantly between the two groups. Based on machine learning algorithms, a further feature selection procedure was performed to identify the features that can contribute the most to the prediction of disease severity. Of the 172 patients, 112 were discharged as mild cases, and 60 developed into severe cases. Four clinical characteristics and 18 laboratory findings showed significant differences between the two groups in the statistical test (<0.01) and univariate logistic regression analysis (<0.01). In the further feature selection procedure, six features were chosen to obtain the best performance in discriminating the two groups with a linear kernel support vector machine. The mean accuracy was 91.38%, with a sensitivity of 0.90 and a specificity of 0.94. The six features included interleukin-6, high-sensitivity cardiac troponin I, procalcitonin, high-sensitivity C-reactive protein, chest distress and calcium level. With the data collected at admission, the combination of one clinical characteristic and five laboratory findings contributed the most to the discrimination between the two groups with a linear kernel support vector machine classifier. These factors may be risk factors that can be used to perform a prognostic prediction regarding the severity of the disease for patients with moderate COVID-19 in the early stage of the disease.

摘要

为了评估武汉中度 COVID-19 患者入院时的特征,并探讨与疾病严重预后相关的危险因素,以便进行预后预测。在这项回顾性研究中,根据世界卫生组织-中国 COVID-19 联合考察组的报告,将中度和重度疾病定义为中度和重度疾病。2020 年 2 月 13 日至 2 月 25 日期间,收集了 172 例经实验室确诊为中度 COVID-19 的患者入院时的临床特征和实验室检查结果。该队列随访至 2020 年 3 月 14 日。将出院为轻症或发展为重症的结局分为两组。采用单因素逻辑回归比较和分析两组间差异有统计学意义的特征。基于机器学习算法,进一步进行特征选择,以确定对疾病严重程度预测贡献最大的特征。在 172 例患者中,112 例出院为轻症,60 例发展为重症。在统计学检验(<0.01)和单因素逻辑回归分析(<0.01)中,两组间有 4 项临床特征和 18 项实验室检查结果有显著差异。在进一步的特征选择过程中,使用线性核支持向量机选择了 6 个特征来获得最佳的两组区分性能。平均准确率为 91.38%,敏感性为 0.90,特异性为 0.94。这 6 个特征包括白细胞介素 6、高敏心肌肌钙蛋白 I、降钙素原、高敏 C 反应蛋白、胸部不适和钙水平。使用入院时收集的数据,线性核支持向量机分类器对两组的区分贡献最大的是一个临床特征和五个实验室检查结果。这些因素可能是风险因素,可用于对疾病早期中度 COVID-19 患者的疾病严重程度进行预后预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/4c547887ea44/ijmsv18p0120g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/03598357e7df/ijmsv18p0120g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/15f69aa4591f/ijmsv18p0120g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/4c547887ea44/ijmsv18p0120g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/03598357e7df/ijmsv18p0120g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/15f69aa4591f/ijmsv18p0120g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0933/7738952/4c547887ea44/ijmsv18p0120g003.jpg

相似文献

1
Risk factors related to the severity of COVID-19 in Wuhan.武汉 COVID-19 严重程度相关的风险因素。
Int J Med Sci. 2021 Jan 1;18(1):120-127. doi: 10.7150/ijms.47193. eCollection 2021.
2
Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study.基于临床和炎症特征的机器学习模型对住院 COVID-19 患者死亡风险的预测:一项回顾性队列研究的结果。
Ann Med. 2021 Dec;53(1):257-266. doi: 10.1080/07853890.2020.1868564.
3
Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study.中国武汉以外地区 2019 年冠状病毒病(COVID-19)患者的临床特征:一项病例对照研究。
BMC Infect Dis. 2021 Feb 24;21(1):207. doi: 10.1186/s12879-021-05897-z.
4
The Development and Validation of Simplified Machine Learning Algorithms to Predict Prognosis of Hospitalized Patients With COVID-19: Multicenter, Retrospective Study.中文译文:简化机器学习算法预测 COVID-19 住院患者预后的开发和验证:多中心回顾性研究。
J Med Internet Res. 2022 Jan 21;24(1):e31549. doi: 10.2196/31549.
5
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.超重在新型冠状病毒肺炎中的重要性:中国武汉某单中心回顾性分析
Medicine (Baltimore). 2020 Oct 23;99(43):e22766. doi: 10.1097/MD.0000000000022766.
6
Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China.临床预测因素对 COVID-19 疾病进展和死亡的影响:来自中国武汉 214 例住院患者的分析。
Clin Respir J. 2021 Mar;15(3):293-309. doi: 10.1111/crj.13296. Epub 2020 Nov 8.
7
Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.与 COVID-19 患者急性心脏损伤相关的因素及其对死亡率的影响。
Sci Rep. 2020 Nov 24;10(1):20452. doi: 10.1038/s41598-020-77172-1.
8
Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.新型冠状病毒肺炎非重症患者临床恶化的预测因素:一项回顾性队列研究。
Curr Med Res Opin. 2021 Mar;37(3):385-391. doi: 10.1080/03007995.2021.1876005. Epub 2021 Feb 4.
9
Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.新型冠状病毒病患者肝功能生化指标升高的临床特征:一项多中心回顾性研究。
Hepatology. 2021 Apr;73(4):1509-1520. doi: 10.1002/hep.31446. Epub 2020 Dec 22.
10
The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.SOFA 评分在 COVID-19 患者中的预后价值:一项回顾性、观察性研究。
Medicine (Baltimore). 2021 Aug 13;100(32):e26900. doi: 10.1097/MD.0000000000026900.

引用本文的文献

1
Clinical Characteristics and Prognostic Factors of Severe COVID-19.重症新型冠状病毒肺炎的临床特征及预后因素
Infect Drug Resist. 2025 Jun 25;18:3117-3125. doi: 10.2147/IDR.S525970. eCollection 2025.
2
Prediction models based on machine learning algorithms for COVID-19 severity risk.基于机器学习算法的新型冠状病毒肺炎严重程度风险预测模型。
BMC Public Health. 2025 May 13;25(1):1748. doi: 10.1186/s12889-025-22976-x.
3
Clinical Features Predicting COVID-19 Severity Risk at the Time of Hospitalization.住院时预测COVID-19严重程度风险的临床特征。

本文引用的文献

1
Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.与严重新型冠状病毒病(COVID-19)患者死亡结局相关的因素:病例对照研究。
Int J Med Sci. 2020 May 18;17(9):1281-1292. doi: 10.7150/ijms.46614. eCollection 2020.
2
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
3
Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China.
Cureus. 2024 Mar 31;16(3):e57336. doi: 10.7759/cureus.57336. eCollection 2024 Mar.
4
Associated Biochemical and Hematological Markers in COVID-19 Severity Prediction.新冠病毒疾病严重程度预测中的相关生化和血液学标志物
Adv Med. 2023 Oct 19;2023:6216528. doi: 10.1155/2023/6216528. eCollection 2023.
5
Prognostic Performance of Cystatin C in COVID-19: A Systematic Review and Meta-Analysis.胱抑素 C 对 COVID-19 预后评估的价值:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Nov 7;19(21):14607. doi: 10.3390/ijerph192114607.
6
Deep-Risk: Deep Learning-Based Mortality Risk Predictive Models for COVID-19.深度风险:基于深度学习的新冠病毒疾病死亡风险预测模型
Diagnostics (Basel). 2022 Jul 30;12(8):1847. doi: 10.3390/diagnostics12081847.
7
Prone position reduces the risk of patients with mild or moderate COVID-19 progressing to severe or even critical cases: a retrospective study.俯卧位可降低轻症或普通型 COVID-19 患者向重症甚至危重症进展的风险:一项回顾性研究。
Eur J Med Res. 2022 Aug 12;27(1):149. doi: 10.1186/s40001-022-00776-y.
8
Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies.多效性白细胞介素-6(IL-6)和白细胞介素-10(IL-10)水平升高与COVID-19的严重程度和死亡率密切相关:对147项研究的最新纵向荟萃分析和系统评价
Biomark Insights. 2022 Jun 16;17:11772719221106600. doi: 10.1177/11772719221106600. eCollection 2022.
9
Validation of a Classification Model Using Complete Blood Count to Predict Severe Human Adenovirus Lower Respiratory Tract Infections in Pediatric Cases.使用全血细胞计数预测小儿严重人腺病毒下呼吸道感染的分类模型验证
Front Pediatr. 2022 May 27;10:896606. doi: 10.3389/fped.2022.896606. eCollection 2022.
10
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.基于年龄和实验室检查结果的湖南省重症新型冠状病毒肺炎预测列线图的开发与验证
Ther Clin Risk Manag. 2022 May 17;18:579-591. doi: 10.2147/TCRM.S361936. eCollection 2022.
中国武汉 93 例 COVID-19 患者的临床和影像学表现与结局的相关性研究。
Theranostics. 2020 May 15;10(14):6113-6121. doi: 10.7150/thno.46569. eCollection 2020.
4
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.中国全国范围内分析的 2019 年冠状病毒病住院患者死亡结局的危险因素。
Chest. 2020 Jul;158(1):97-105. doi: 10.1016/j.chest.2020.04.010. Epub 2020 Apr 15.
5
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
6
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病(COVID-19)的重症监护管理:挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
7
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.预测 SARS-CoV-2 引起的 COVID-19 肺炎患者死亡率的前瞻性队列研究。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.00524-2020. Print 2020 May.
8
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19.344例新冠肺炎重症监护患者的临床病程及预后
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434. doi: 10.1164/rccm.202003-0736LE.
9
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.
10
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.中国浙江 36 例 2019 冠状病毒病(COVID-19)患儿的临床和流行病学特征:一项观察性队列研究。
Lancet Infect Dis. 2020 Jun;20(6):689-696. doi: 10.1016/S1473-3099(20)30198-5. Epub 2020 Mar 25.